Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Consistent benefits with lecanemab seen in Clarity AD Asian cohort

Consistent benefits with lecanemab seen in Clarity AD Asian cohort

19 Apr 2025 bởiJairia Dela Cruz

In the treatment of early Alzheimer’s disease (AD), lecanemab is as safe and efficacious in Asian patients as in the wider Clarity AD population, slowing cognitive decline and reducing amyloid levels in the brain with manageable risks.

Consistent benefits with lecanemab seen in Clarity AD Asian cohort

19 Apr 2025
Etripamil nasal spray safe, effective against PSVT

Etripamil nasal spray safe, effective against PSVT

19 Apr 2025
3-year RUBY data support add-on dostarlimab as frontline Tx for endometrial cancer

3-year RUBY data support add-on dostarlimab as frontline Tx for endometrial cancer

17 Apr 2025